RecruitingNot Applicable

Berlin Registry of Right Heart Interventions

Germany200 participantsStarted 2020-06-16

Plain-language summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with planned or recent valve interventions of the right heart (tricuspid regurgitation/ stenosis, pulmonary regurgitation/ stenosis) * \>18 years * Written, documented consent Exclusion Criteria: * Patients in care or unable to consent * Patients who are unable to comply with follow-up examinations * Patients who are detained in an institution

What they're measuring

Overall mortality

Timeframe: 2 months after intervention

Cardiovascular mortality

Timeframe: 2 months after intervention

Unscheduled hospitalization for heart failure progression

Timeframe: 2 months after intervention

Trial details

NCT IDNCT04570163

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2035-12-31

Contact for this trial

Henryk Dreger, Prof. Dr. med.

+4930450613496 henryk.dreger@charite.de

View on ClinicalTrials.gov More Tricuspid Regurgitation trials